Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K251116
    Device Name
    Luja Coudé
    Manufacturer
    Date Cleared
    2025-06-27

    (77 days)

    Product Code
    Regulation Number
    876.5130
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Luja Coudé

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Luja Coudé is indicated for use by patients with urine retention and patients with post void residual volume (PVR) due to neurogenic and non-neurogenic voiding dysfunction. The catheter is inserted into the urethra to reach the bladder allowing urine to drain.

    The product is for male patients only (adults and pediatric above the age of 1 years).

    Device Description

    The Luja Coude is a single-use, sterile, hydrophilic coated catheter for intermittent urinary catheterization. The catheter has a flexible tip which contains several small holes (micro holes) by the tip creating a drainage zone which allows the urine to flow from the bladder through the catheter. The drainage end of the device has an outlet to which a urine bag with a suitable connector can be connected. The catheter also contains a hydrophilic-coating and is sterilized by irradiation.

    The primary packaging provides the sterile barrier and contains a proof of seal for identification of opened products.

    The Luja Coude is available in one length (33cm) with a flexible tip and diameters of 8 Fr, 10 Fr, 12 Fr, 14 Fr, 16 Fr, and 18 Fr.

    AI/ML Overview

    The provided FDA 510(k) clearance letter and supporting Traditional 510(k) summary pertain to a urological catheter (Luja Coudé) and its substantial equivalence to a predicate device. This document focuses on the mechanical and material properties of the catheter, not on an AI/software as a medical device (SaMD) or diagnostic imaging device.

    Therefore, many of the requested details, such as MRMC comparative effectiveness studies, standalone algorithm performance, AI training/test sets, expert ground truth establishment, and complex adjudication methods, are not applicable to this type of medical device submission. These elements are typically required for AI/ML-based diagnostic devices where performance is measured in terms of diagnostic accuracy (e.g., sensitivity, specificity, AUC) and reader improvement.

    The provided information focuses on bench testing (non-clinical performance) to demonstrate the device's physical and biological properties meet established standards and are equivalent to the predicate.

    Here's an analysis of the provided text in relation to your questions, highlighting what is available and what is not:


    Analysis of Acceptance Criteria and Study Proof for Luja Coudé Catheter

    Based on the provided FDA 510(k) clearance letter and Traditional 510(k) summary, the Luja Coudé catheter demonstrates its performance through non-clinical (bench) testing and biocompatibility assessments, rather than clinical studies or AI/ML performance evaluations involving human readers.

    1. Table of Acceptance Criteria and Reported Device Performance

    The document states that "Biocompatibility and bench performance testing were conducted to verify the proposed subject devices with modified hydrophilic coating met the pre-determined acceptance criteria per specified requirements." It also states, "The subject devices met the pre-determined acceptance criteria after simulated shipping distribution and aging cycle per specified performance requirements."

    However, the specific numerical acceptance criteria or the exact reported performance values are not detailed in this public summary. Instead, the summary lists the tests conducted and confirms that the device met the criteria.

    CategoryTest Performed / Standard AppliedAcceptance Criteria (Implied: Met)Reported Device Performance (Implied: Met Criteria)
    BiocompatibilityISO 10993-1:2018 (General Evaluation)Safe for intended useBiologically compatible
    ISO 10993-5:2009 (Cytotoxicity)Non-cytotoxicNon-cytotoxic
    ISO 10993-10:2021 (Irritation & Sensitization)Non-irritating, Non-sensitizingNon-irritating, Non-sensitizing
    ISO 10993-11:2017 (Systemic Toxicity)No systemic toxicityNo systemic toxicity
    ISO 10993-12:2021 (Sample Prep)(Methodology Standard)(Methodology Standard)
    ISO 10993-23:2021 (Irritation)Non-irritatingNon-irritating
    USP (Pyrogen Test)Non-pyrogenicNon-pyrogenic
    Catheter PerformanceISO 20696:2018 (Sterile urethral catheters for single use)Meets ISO performance reqsMeets ISO performance reqs
    Coloplast TM6030 (Friction at T=0 minutes)(Proprietary Criteria)Met proprietary criteria
    Coloplast TM6058 (Friction after 5 minutes)(Proprietary Criteria)Met proprietary criteria
    Coloplast TM6129 (Kink of catheter tubes)(Proprietary Criteria)Met proprietary criteria
    Coloplast TM0507 & TM6032 (pH and Osmolality)(Proprietary Criteria)Met proprietary criteria
    Shipping & AgingASTM D4169-22 (Simulated shipping distribution)Performance retainedPerformance retained
    ASTM F1980-21 (Accelerated aging)Performance retained, 2-year shelf lifePerformance retained, 2-year shelf life
    SterilitySAL 10⁻⁶AchievedAchieved

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size for Test Set: The document does not specify exact sample sizes for each non-clinical test (e.g., number of catheters tested for friction, kink, etc.). It only states that "Testing was performed on final, finished, and sterilized devices." This is typical for bench testing where the number of units tested is governed by standard protocols (e.g., ISO, ASTM, internal methods) to achieve statistical confidence for manufacturing and design verification, but individual numbers are not usually disclosed in 510(k) summaries unless a specific, novel statistical method for performance testing is employed.
    • Data Provenance: The studies are "non-clinical" (bench testing). Therefore, concepts like "country of origin of the data" or "retrospective/prospective" studies do not apply in the context of human subject data. The device is manufactured by Coloplast A/S in Humlebæk, Denmark, and the tests would have been performed in a controlled laboratory environment.

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of Experts

    • Not Applicable. For this type of device (a physical urological catheter), "ground truth" is established through physical measurements, chemical analysis, and standardized biological assessments in a lab setting, not by human experts interpreting clinical data (like radiologists interpreting images). The "experts" involved would be engineers, material scientists, and microbiologists conducting the tests.

    4. Adjudication Method for the Test Set

    • Not Applicable. Adjudication methods (e.g., 2+1, 3+1) are used to resolve discrepancies among human readers/experts in diagnostic studies, typically for AI/ML device validation. This is not relevant for the bench testing of a physical catheter.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, and the effect size of how much human readers improve with AI vs without AI assistance

    • No. An MRMC study is relevant for AI/ML-driven diagnostic devices where the AI assists human readers. This device is a physical medical instrument, not an AI diagnostic tool.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

    • No. This question applies to AI algorithms. The Luja Coudé is a physical catheter designed for direct patient use via insertion, not an algorithm.

    7. The Type of Ground Truth Used

    • For this device, the "ground truth" is based on:
      • Standardized Bench Test Measurements: Objective physical properties (e.g., friction coefficients, kink resistance, dimensions, pH, osmolality) measured against international and proprietary Coloplast standards (ISO 20696, Coloplast TMs).
      • Biocompatibility Testing: Laboratory assays and in-vivo animal models (for systemic toxicity, irritation, sensitization) that demonstrate the material's safety in a biological environment, conforming to ISO 10993 standards.
      • Sterility Assurance Level (SAL): Defined by microbial inactivation standards (SAL 10⁻⁶).

    8. The Sample Size for the Training Set

    • Not Applicable. The concept of a "training set" is for AI/ML models. This device does not use an AI/ML model. The design and manufacturing process for the catheter would involve extensive development and testing, but not in the sense of an "AI training set."

    9. How the Ground Truth for the Training Set was Established

    • Not Applicable. As there is no AI training set, there is no ground truth to establish for it. The development of the catheter relies on established engineering principles, material science, and manufacturing quality control.

    Summary: The provided document is a 510(k) summary for a physical medical device (catheter) that relies on non-clinical bench testing and biocompatibility assessments to demonstrate substantial equivalence and safety/effectiveness. It does not involve AI/ML technology or human reader studies. Therefore, many of the questions related to AI/ML device validation are not applicable.

    Ask a Question

    Ask a specific question about this device

    Why did this record match?
    Device Name :

    Luja Coudé (20118 Male CH8 - small packaging (Pocket size)), Luja Coudé (20111 Male CH10 - small packaging
    (Pocket size)), Luja Coudé (20112 Male CH12 - small packaging (Pocket size)), Luja Coudé (20114 Male
    CH14 - small packaging (Pocket size)), Luja Coudé (20101 Male CH10 - large packaging), Luja Coudé
    (20102 Male CH12 - large packaging), Luja Coudé (20104 Male CH14 - large packaging), Luja Coudé (20106

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Luja Coude is indicated for use by patients with urine retention and patients with post void residual volume (PVR) due to neurogenic and non-neurogenic voiding dysfunction. The catheter is inserted into the bladder allowing urine to drain. The product is for adult male patients only.

    Device Description

    Luja Coude is a single-use, sterile catheter for intermittent urinary catheterization. The catheter has a flexible tip which contains several small holes (micro holes) by the tip creating a drainage zone which allows the urine to flow from the bladder through the catheter. The drainage end of the device has an outlet to which a urine bag with a suitable connector can be connected. The catheter also contains a hydrophilic-coating and is sterilized by irradiation. The primary packaging provides the sterile barrier and contains a proof of seal for identification of opened products. Luja Coude is available in one length (33cm) with a flexible tip and diameters of 8 Fr, 10 Fr, 12 Fr, 14 Fr, and 16 Fr. The reference device supports the inclusion of 8 Fr models.

    AI/ML Overview

    The provided text describes the acceptance criteria and the studies performed for the Luja Coude urological catheter. However, it does not contain information relevant to AI/ML device performance, ground truth establishment for a training set, MRMC studies, or standalone algorithm performance. The device is a traditional medical device, not an AI/ML device.

    Therefore, many of the requested fields cannot be answered from the provided document.

    Here's a summary of the available information:

    1. Table of Acceptance Criteria and Reported Device Performance:

    The document lists various non-clinical performance tests and associated standards. The general reported performance is that the "proposed subject devices met the pre-determined acceptance criteria per specified requirements" and "The performance testing demonstrates the subject device is as safe and effective as the predicate device." Specific numerical acceptance criteria and performance results are not provided in this summary.

    Test CategoryStudy/StandardAcceptance Criteria (General)Reported Performance (General)
    BiocompatibilityISO 10993-1, -5, -10, -11, -18, -23Not explicitly stated in detail, but implied compliance with these ISO standards.Addressed cytotoxicity, irritation or intracutaneous reactivity, sensitization, material mediated pyrogenicity, acute systemic toxicity, and subacute toxicity, implying meeting the requirements of these standards.
    Catheter PerformanceISO 20696:2018, ASTM F623-19, ASTM D1894:2014, Coloplast Test Methods (TM 6058, TM 6059, TM 6100, TM6129), EN/IEC 62366-1:2015/A1:2020Not explicitly stated in detail, but implied compliance with these standards and internal test methods.Bench performance testing and usability testing were conducted to verify the proposed subject devices met the pre-determined acceptance criteria per specified requirements. These tests included friction, opening torque, sleeve collapse force, and kink/coude measurements.
    PackagingISO 11607-1:2019, ASTM F2096, EN 868-5, ASTM F88/FM88, ASTM D4169-22Not explicitly stated in detail, but implied compliance with these standards.Packaging integrity testing verified maintenance of the sterile barrier through shelf life. Transportation testing verified no impact to device safety or efficacy due to transportation hazards.
    Aging/StabilityASTM F1980-21Properties meet acceptance criteria after aging cycle.The stability study investigated product properties over shelf-life. The properties met the acceptance criteria after the aging cycle, deeming the device stable for the defined shelf life (8 months at submission, planned 2 years).

    2. Sample size used for the test set and the data provenance:
    Not applicable information for the provided device type. The device is a physical catheter, and the testing involves bench performance and biocompatibility rather than a "test set" of data in the AI/ML context.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
    Not applicable. This is not an AI/ML device requiring expert-established ground truth for a test set.

    4. Adjudication method for the test set:
    Not applicable. This is not an AI/ML device requiring adjudication of a test set.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
    Not applicable. This is not an AI/ML device.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
    Not applicable. This is not an AI/ML device.

    7. The type of ground truth used:
    Not applicable. The "ground truth" for this device's performance is established through physical and biological testing against established international and ASTM standards, as well as Coloplast's internal test methods.

    8. The sample size for the training set:
    Not applicable. This is not an AI/ML device.

    9. How the ground truth for the training set was established:
    Not applicable. This is not an AI/ML device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1